REQUEST A DEMO
Total
USD $0.00
Search more companies

Pontus Pharma d.o.o. (Croatia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pontus Pharma d.o.o. Profile Updated: July 21, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Pontus Pharma d.o.o. is a company in Croatia, with a head office in Zagreb. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Pontus Pharma d.o.o. was incorporated on July 23, 2026. 22 (2025) employees currently work for Pontus Pharma d.o.o.. From the latest financial highlights, Pontus Pharma d.o.o. reported a net sales revenue increase of 5.45% in 2025. Its’ total assets recorded a growth of 46.43%. The net profit margin of Pontus Pharma d.o.o. increased by 0.53% in 2025.

Headquarters
Kralja Zvonimira 62 Str.
Zagreb; City of Zagreb; Postal Code: 10000

Contact Details: Purchase the Pontus Pharma d.o.o. report to view the information.

Website: http://www.pontus-pharma.com

Basic Information
Total Employees:
Purchase the Pontus Pharma d.o.o. report to view the information.
Financial Auditors:
Purchase the Pontus Pharma d.o.o. report to view the information.
Incorporation Date:
July 23, 2026
Key Executives
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Pontus Pharma D.O.O. Beograd (Serbia)
Company Performance
Financial values in the chart are available after Pontus Pharma d.o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
5.45%
Total Operating Revenue
5.45%
Operating Profit
-2.61%
EBITDA
2.42%
Net Profit/Loss for the Period
76.64%
Total Assets
46.43%
Total Equity
13.23%
Operating Profit Margin
-0.19%
Net Profit Margin
0.53%
Return on Equity (ROE)
4.81%
Debt / Equity
87.44%
Quick Ratio
0.04%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?